A new vaccine to protect against meningococcus B, a common cause of bacterial meningitis, shows promise in clinical trials, researchers in Chile report.
Vaccines that protect from four other strains of Neisseria meningitides, a bacteria that causes meningococcal disease, are already in use or in the last stages of development, according to a news release from The Lancet. The other strains include A, C, W135 and Y.
The new research examined the effectiveness of the vaccine for strain B, which remains a significant source of meningococcal disease in North America, South America and Europe.
Click "source" for entire article.